ThomasGregoryKnightMD

PubMed

• Evaluation of pentamidine tolerability and efficacy betweenphenotypes.
  Alexis Koon, Jiaxian He, Jai Patel, Allison Morse, Victoria Boseman, Alicia Hamilton, Thomas Knight, Nilay Shah, Brittany Ragon, Aleksander Chojecki, Jing Ai, Nury Ste...> ;Pharmacogenomics. 2023 Oct 1
• Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions.
  Megan Sears-Smith, Thomas G Knight> ;Current Hematologic Malignancy Reports. 2023 Oct 1
• 1 citations
  Financial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic review.
  Orrin Pail, Thomas G Knight> ;Best Practice & Research. Clinical Haematology. 2023 Jun 1
• 1 citations
  Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
  Aleksander L Chojecki, Justin Arnall, Danielle Boselli, Rushil Patel, Zane Chiad, Kristyn Y DiSogra, Allison Karabinos, Tommy Chen, Adilen Cruz, Allison Verbyla, Jing ...> ;Leukemia Research. 2022 Aug 1
• 11 citations
  Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.
  Thomas G Knight, Melissa Aguiar, Myra Robinson, Allison Morse, Tommy Chen, Rupali Bose, Jing Ai, Brittany K Ragon, Aleksander L Chojecki, Nilay A Shah, Srinivasa R San...> ;JCO Oncology Practice. 2022 Sep 1
• Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).
  Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, Nicole Cowgill, Amy Soni, Charles H Packman, Srinivasa Reddy Sanikommu, Nilay A Shah, Brittany K Ragon, Thomas...> ;Leukemia & Lymphoma. 2022 Jun 1
• 19 citations
  Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem
  Derek Raghavan, Nicole A. Keith, Hughes R. Warden, Seungjean Chai, Wendy Jo Turan, Jaynie Moroe, Donna Feild, Thomas Gregory Knight> ;JCO Oncology Practice. 2021 Jun 8
• Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematology.
  Lucas S Wind, Thomas G. Knight, Jessica J Auten, Jill S Bates, Leonardo Marucci, Crista J Creedle, Matthew C. Foster, Benyam Muluneh> ;Journal of Oncology Pharmacy Practice. 2021 Mar 1
• 1 citations
  Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?
  Thomas G. Knight> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
• 36 citations
  Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation
  Olivia Copelan, Srinivasa R. Sanikommu, Jigar Trivedi, Candace Butler, Jing Ai, Brittany K. Ragon, Ryan Jacobs, Thomas G. Knight, Saad Z. Usmani, Michael R. Grunwald, ...> ;Biology of Blood and Marrow Transplantation. 2019 Apr 1
• 99 citations
  Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance
  Thomas G. Knight, Allison M. Deal, Stacie B. Dusetzina, Hyman Bernard Muss, Seul Ki Choi, Jeannette T. Bensen, Grant R. Williams> ;Journal of Oncology Practice. 2018 Oct 24
• Join now to see all

Lectures

• Patient Reported Financial Toxicity in Myeloproliferative Neoplasms 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019